Ameriprise
EW icon

Ameriprise’s Edwards Lifesciences EW Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$54.9M Sell
704,514
-50,523
-7% -$3.94M 0.01% 807
2025
Q1
$54.6M Sell
755,037
-2,062
-0.3% -$149K 0.01% 798
2024
Q4
$56.1M Sell
757,099
-1,332,490
-64% -$98.7M 0.01% 781
2024
Q3
$138M Sell
2,089,589
-1,113,141
-35% -$73.4M 0.04% 439
2024
Q2
$296M Buy
3,202,730
+747,771
+30% +$69.1M 0.08% 254
2024
Q1
$236M Buy
2,454,959
+633,858
+35% +$60.9M 0.06% 303
2023
Q4
$141M Buy
1,821,101
+136,290
+8% +$10.5M 0.04% 410
2023
Q3
$115M Sell
1,684,811
-418,967
-20% -$28.7M 0.04% 438
2023
Q2
$198M Sell
2,103,778
-96,130
-4% -$9.07M 0.06% 309
2023
Q1
$182M Buy
2,199,908
+21,090
+1% +$1.74M 0.06% 319
2022
Q4
$163M Sell
2,178,818
-1,237,435
-36% -$92.3M 0.06% 348
2022
Q3
$283M Sell
3,416,253
-426,967
-11% -$35.3M 0.1% 213
2022
Q2
$365M Buy
3,843,220
+873,155
+29% +$82.9M 0.13% 173
2022
Q1
$348M Buy
2,970,065
+214,484
+8% +$25.1M 0.1% 217
2021
Q4
$355M Sell
2,755,581
-551,182
-17% -$70.9M 0.1% 215
2021
Q3
$374M Sell
3,306,763
-1,757,652
-35% -$199M 0.12% 188
2021
Q2
$524M Buy
5,064,415
+33,525
+0.7% +$3.47M 0.16% 137
2021
Q1
$421M Buy
5,030,890
+1,381,907
+38% +$116M 0.14% 159
2020
Q4
$333M Sell
3,648,983
-174,265
-5% -$15.9M 0.12% 184
2020
Q3
$305M Sell
3,823,248
-78,747
-2% -$6.28M 0.12% 179
2020
Q2
$270M Buy
3,901,995
+2,740,924
+236% +$189M 0.12% 191
2020
Q1
$219M Sell
1,161,071
-369,643
-24% -$69.7M 0.11% 188
2019
Q4
$357M Sell
1,530,714
-151,811
-9% -$35.4M 0.15% 150
2019
Q3
$370M Sell
1,682,525
-194,955
-10% -$42.9M 0.17% 126
2019
Q2
$347M Sell
1,877,480
-38,559
-2% -$7.12M 0.16% 134
2019
Q1
$367M Sell
1,916,039
-269,112
-12% -$51.5M 0.17% 125
2018
Q4
$334M Sell
2,185,151
-57,726
-3% -$8.83M 0.17% 130
2018
Q3
$390M Sell
2,242,877
-92,874
-4% -$16.1M 0.14% 171
2018
Q2
$340M Sell
2,335,751
-575,355
-20% -$83.8M 0.15% 143
2018
Q1
$406M Sell
2,911,106
-884,260
-23% -$123M 0.18% 120
2017
Q4
$428M Sell
3,795,366
-436,109
-10% -$49.2M 0.2% 110
2017
Q3
$463M Sell
4,231,475
-128,212
-3% -$14M 0.22% 100
2017
Q2
$515M Sell
4,359,687
-1,377,772
-24% -$163M 0.26% 83
2017
Q1
$540M Buy
5,737,459
+850,168
+17% +$80M 0.28% 77
2016
Q4
$458M Buy
4,887,291
+566,688
+13% +$53.1M 0.25% 82
2016
Q3
$521M Buy
4,320,603
+66,627
+2% +$8.03M 0.29% 72
2016
Q2
$424M Buy
4,253,976
+1,632,567
+62% +$163M 0.25% 84
2016
Q1
$231M Buy
2,621,409
+2,310,398
+743% +$204M 0.14% 160
2015
Q4
$24.3M Buy
311,011
+146,517
+89% +$11.5M 0.01% 825
2015
Q3
$23.2M Buy
164,494
+110,963
+207% +$15.7M 0.01% 840
2015
Q2
$7.63M Buy
53,531
+7,475
+16% +$1.07M ﹤0.01% 1814
2015
Q1
$6.53M Sell
46,056
-52,545
-53% -$7.45M ﹤0.01% 1919
2014
Q4
$12.5M Buy
98,601
+38,942
+65% +$4.96M 0.01% 1315
2014
Q3
$6.09M Buy
59,659
+22,802
+62% +$2.33M ﹤0.01% 1893
2014
Q2
$3.16M Sell
36,857
-281
-0.8% -$24.1K ﹤0.01% 2326
2014
Q1
$2.75M Sell
37,138
-16,938
-31% -$1.26M ﹤0.01% 2354
2013
Q4
$3.56M Sell
54,076
-4,800
-8% -$316K ﹤0.01% 2200
2013
Q3
$4.1M Sell
58,876
-4,745,375
-99% -$330M ﹤0.01% 2071
2013
Q2
$323M Buy
+4,804,251
New +$323M 0.22% 98